… Fibroblasts and myofibroblasts are the key cells in the fibrotic process. Recently two drugs,
pirfenidone and nintedanib, were … the effects of pirfenidone and nintedanib on fibroblasts and …

… of HSP47 and FKBP10 by nintedanib and pirfenidone in IPF and donor fibroblasts. Notably,
… the effect of nintedanib and pirfenidone on fibroblast and myofibroblast properties and also …

… The reduction in fibroblast-specific protein-positive cells with both pirfenidone and … effects
of nintedanib and pirfenidone in human lung tissue displaying early features of fibrosis after …

… Nintedanib has been shown to inhibit various fibroblast functions, such as proliferation, fibroblast
… /or effects on cells other than fibroblasts could contribute to the anti-fibrotic properties of …

… -fibrotic drugs nintedanib and pirfenidone on the CM–fibroblast … formation, nintedanib was
more effective than pirfenidone in … However, nintedanib at 100 nmol/L did not significantly …

… Treatment of IPF with pirfenidone or nintedanib does not stop ongoing fibrosis … fibroblasts
were used in this study as IPF-derived fibroblasts are known to display morphological features …

… We wanted to test the effect of pirfenidone and rapamycin on tenascin-c in lung fibroblasts
from IPF patients treated with the pro-fibrotic factor TGF−β. As shown in Fig. 2a, b, we found …

… Pirfenidone and nintedanib are antifibrotic medications … with antifibrotic properties, such as
pirfenidone and nintedanib, may … on the efficacy of pirfenidone and nintedanib in ILDs other …

… The objective of this study was to quantify the impact of pirfenidone or nintedanib treatment
… fibrosis, fibroblast foci and alveolar macrophages in untreated or pirfenidone- or nintedanib-…

… of nintedanib and pirfenidone on pulmonary artery endothelial and smooth muscle cell
remodeling induced by IL-11 in vitro. Our results show that nintedanib (NTD) and pirfenidone (…